Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy

JAMA Ophthalmology Author Interviews
07/08/2025 17 min
Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy

Listen "Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy"

Descargar episodio Ver en sitio original

Episode Synopsis

Interview with Ehsan Rahimy, MD, author of Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention of Proliferative Vitreoretinopathy. Hosted by Neil Bressler, MD. Related Content: Mammalian Target Rapamycin Inhibition as a Therapeutic Target for Prevention of Proliferative Vitreoretinopathy

More episodes of the podcast JAMA Ophthalmology Author Interviews

Retinal Sensitivity and Retinal Perfusion in Diabetic Retinopathy 30/10/2025
Diabetes in the Donor and Descemet Membrane Endothelial Keratoplasty Success at 1 Year 17/10/2025
Smooth Pursuit Velocity After a Season of Repetitive Head Impacts in American Football Players 18/09/2025
Steroids and Cross-Linking for Ulcer Treatment 24/07/2025
From the JAMA Network: GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension 17/07/2025
Gender Differences in Case Volume Among Ophthalmology Resident Graduates, 2014-2023 01/05/2025
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab 06/03/2025
Shedding LiGHT on Selective Laser Trabeculoplasty 20/02/2025
Ophthalmic Complications Associated With Semaglutide and Tirzepatide 30/01/2025
Ultra-Widefield Optical Coherence Tomography Beyond the Ora Serrata in ROP 26/12/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA